bivalirudin
Active substance: bivalirudin
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · BIVALIRUDIN 250 mg/1
United StatesActive
Marketing holder: Slate Run Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BIVALIRUDIN · 250 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5982-7135-a44f-e3627116da35,01a1208c-c1d3-765b-ba49-ce2e95370e15,01a1208d-d98b-7b3a-a4ca-9bbaf912fb16,01a1208e-d7da-7c4f-a635-d66b07491c62,01a12090-4162-7455-b951-3ce8a6b26062;count=13 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70436-025
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 70436-025 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70436-025 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70436-025 · Verified 2026-10-09 · open in source